Home Cart 0 Sign in  
X

[ CAS No. 159603-71-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 159603-71-1
Chemical Structure| 159603-71-1
Chemical Structure| 159603-71-1
Structure of 159603-71-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 159603-71-1 ]

Related Doc. of [ 159603-71-1 ]

Alternatived Products of [ 159603-71-1 ]

Product Details of [ 159603-71-1 ]

CAS No. :159603-71-1 MDL No. :MFCD09030821
Formula : C10H13ClN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :UEYNRRQJJHZENW-UHFFFAOYSA-N
M.W : 228.68 Pubchem ID :11253185
Synonyms :

Calculated chemistry of [ 159603-71-1 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.4
Num. rotatable bonds : 4
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 59.49
TPSA : 51.22 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.77 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.33
Log Po/w (XLOGP3) : 2.71
Log Po/w (WLOGP) : 2.89
Log Po/w (MLOGP) : 1.8
Log Po/w (SILICOS-IT) : 1.78
Consensus Log Po/w : 2.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.0
Solubility : 0.23 mg/ml ; 0.00101 mol/l
Class : Soluble
Log S (Ali) : -3.44
Solubility : 0.0832 mg/ml ; 0.000364 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.6
Solubility : 0.0574 mg/ml ; 0.000251 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.43

Safety of [ 159603-71-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 159603-71-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 159603-71-1 ]
  • Downstream synthetic route of [ 159603-71-1 ]

[ 159603-71-1 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 159603-71-1 ]
  • [ 45644-21-1 ]
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 10, p. 2025 - 2034
  • 2
  • [ 159603-71-1 ]
  • [ 17920-35-3 ]
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 10, p. 2025 - 2034
  • 3
  • [ 159603-71-1 ]
  • [ 73896-36-3 ]
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 10, p. 2025 - 2034
  • 4
  • [ 45644-21-1 ]
  • [ 24424-99-5 ]
  • [ 159603-71-1 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at 20℃; Inert atmosphere
Stage #2: With hydrogenchloride In water; ethyl acetate
tert-butyl (6-chloro-pyridin-2-yl)-carbamate Under a nitrogen atmosphere a solution of 32.7 g (0.15 mol) BOC anhydride in 100 mL THF was added dropwise at RT to 17.4 g (0.14 mol) 6-chloro-pyridin-2-ylamine and 300 mL (0.30 mol) of a 1 molar sodium hexamethyldisilazide solution in THF in 200 mL THF. The reaction mixture was stirred overnight at RT and then evaporated down. The residue was stirred between EtOAc and 1N aqueous hydrochloric acid solution. The organic phase was separated off and the aqueous phase was again extracted with EtOAc. The combined organic phases were washed with 300 mL saturated sodium hydrogen carbonate solution, dried and evaporated down. The residue was recrystallised from EtOH, the solid was suction filtered and dried.Yield: 29.2 g (95percent of theoretical)ESI-MS: m/z=228 (M+)Rt(HPLC): 1.70 min (method C)
95% With sodium hexamethyldisilazane In tetrahydrofuran at 20℃; Inert atmosphere Step 1: tert-butyl (6-chloro-pyridin-2-yl)-carbamate; Under a nitrogen atmosphere a solution of 32.7 g (0.150 mol) BOC-anhydride in 100 mL THF was added dropwise at RT to a mixture of 17.4 g (0.135 mol) 6-chloropyridin-2-ylamine and 300 mL (0.300 mol) of a sodium hexamethyldisilazide solution (1M in THF) in 200 mL of THF. The reaction mixture was stirred overnight at RT and evaporated down i.vac. The residue was stirred between EtOAc and 1N aqueous hydrochloric acid solution. The organic phase was separated off and the aqueous phase was extracted with EtOAc. The combined organic phases were washed with saturated sodium hydrogen carbonate solution, dried and evaporated down. The residue was recrystallised from EtOH, the solid was suction filtered and dried.Yield: 29.2 g (95percent of theoretical)ESI-MS: m/z=228 (M+)Rt(HPLC): 1.70 min (method B)
95% With sodium hexamethyldisilazane In tetrahydrofuran at 20℃; Inert atmosphere Step 1: tert-butyl (6-chloro-pyridin-2-yl)-carbamate Under a nitrogen atmosphere a solution of 32.74 g (0.15 mol) BOC anhydride in 100 mL THF was added dropwise at RT to 17.36 g (0.14 mol) 6-chloro-pyridin-2-ylamine and 300 mL (0.30 mol) of a 1 molar sodium hexamethyldisilazide solution in THF in 200 mL THF. The reaction mixture was stirred overnight at RT and then evaporated down. The residue was stirred between EtOAc and 1 N aqueous hydrochloric acid solution. The organic phase was separated off and the aqueous phase was extracted again with EtOAc. The combined organic phases were washed with 300 mL saturated sodium hydrogen carbonate solution, dried and evaporated down. The residue was recrystallised from EtOH, the solid was suction filtered and dried overnight in the drying cupboard at 50° C.Yield: 29.20 g (95percent of theoretical)ESI-MS: m/z=228 (M+)Rt(HPLC): 1.70 min (method C)
88% With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; for 0.5 h; Example 11A
tert-Butyl (6-chloropyridin-2-yl)carbamate
Under argon, 150 ml of THF were added to 23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine, and the mixture was cooled to 0° C. 73.3 g (400 mmol) of sodium bis(trimethylsilyl)amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, were added dropwise.
After 15 min, the cooling bath was removed, and stirring was continued at RT for 15 min.
The THF was removed using a rotary evaporator, ethyl acetate and 0.5 N hydrochloric acid were added to the residue and the mixture was extracted.
The organic phase was separated off, dried over magnesium sulphate and concentrated using a rotary evaporator.
The reaction mixture was chromatographed on silica gel (mobile phase dichloromethane/methanol 100percent-->100:3).
This gave 36.54 g (88percent of theory) of the product as a solid.
LCMS (method 3): Rt=2.41 min. (m/z=175 (M+H)+).
1H-NMR (400 MHz, DMSO-d6): δ=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
88% With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; Inert atmosphere Example 105Atert-Butyl (6-chloropyridin-2-yl)carbamate 23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine are mixed with 150 ml of THF under argon and cooled to 0° C. 73.3 g (400 mmol) of bis(trimethylsilyl)sodium amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, are added dropwise. After 15 min, the cooling bath is removed and stirring is continued at RT for 15 min. The THF is removed in a rotary evaporator, and the residue is mixed and extracted with ethyl acetate and 0.5 N hydrochloric acid. The organic phase is separated off, dried over magnesium sulphate and concentrated in a rotary evaporator. The reaction mixture is chromatographed on silica gel (mobile phase dichloromethane/methanol 100percent-->100:3). 36.54 g (88percent of theory) of the product are obtained as a solid.LCMS (method 3): Rt=2.41 min. (m/z=175 (M+H)+).1H-NMR (400 MHz, DMSO-d6): d=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
88% With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; for 0.5 h; Inert atmosphere Example 3Atert-Butyl(6-chloropyridin-2-yl)carbamate; Under argon, 150 ml of THF were added to 23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine, and the mixture was cooled to 0° C. 73.3 g (400 mmol) of sodium bis(trimethylsilyl)amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, were added dropwise. After 15 min, the cooling bath was removed and stirring was continued at RT for 15 min. The THF was removed on a rotary evaporator, ethyl acetate and 0.5N hydrochloric acid were added to the residue and the mixture was extracted. The organic phase was separated off, dried over magnesium sulfate and concentrated on a rotary evaporator. The reaction mixture was chromatographed on silica gel (mobile phase dichloromethane/methanol 100percent-->100:3). This gave 36.54 g (88percent of theory) of the product as a solid.LCMS (Method 3): Rt=2.41 min. (m/z=175 (M+H)+).1H-NMR (400 MHz, DMSO-d6): δ=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
88% With sodium hexamethyldisilazane In tetrahydrofuran at 0 - 20℃; for 0.5 h; Inert atmosphere Example 1A
tert-Butyl (6-chloropyridin-2-yl)carbamate
23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine were admixed with 150 ml of THF under argon and cooled to 0° C. 73.3 g (400 mmol) of sodium bis(trimethylsilyl)amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, were added dropwise.
After 15 min, the cooling bath was removed and the mixture was stirred at RT for a further 15 min.
The THF was removed by rotary evaporation, and the residue was admixed and extracted with ethyl acetate and 0.5 N hydrochloric acid.
The organic phase was removed, dried over magnesium sulphate and concentrated on a rotary evaporator.
The reaction mixture was chromatographed on silica gel (eluent: dichloromethane/methanol 100percent→100:3).
36.54 g (88percent of theory) of the product were obtained in solid form.
LCMS (method 3): Rt=2.41 min (m/z=175 (M+H)+).
1H NMR (400 MHz, DMSO-d6): δ=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
87.4%
Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at 0℃; for 0.0833333 h; Inert atmosphere
Stage #2: at 0 - 20℃; for 1 h;
Sodium hexamethyl disilazane (63.03 g, 343 mmol) was added portion-wise to a stirred solution of 2-chloro-6-aminopyridine (20.0 g, 156.25 mmol) in THF (100 mL) at 0° C. under argon.
After 5 minutes of stirring at the same temperature, di-tertiary-butyl dicarbonate (36.77 mL, 171 mmol) was added drop-wise into the reaction mixture.
After 15 minutes of additional stirring at the same temperature, the reaction temperature was brought to room temperature and stirred until starting material was consumed completely (1 hour, monitored by silica gel TLC using ethyl acetate-hexanes, 1:9 as mobile phase).
THF was distilled off under reduced pressure, the obtained residue was taken up in ethyl acetate (300 mL), washed with an aqueous solution of 0.5 M HCl (100 mL), water (2*75 mL), dried over anhydrous sodium sulfate, filtered and concentrated on the rotary evaporator to obtain a gummy mass, which was purified over silica gel column chromatography (eluant:EtOAc-hexanes, 1:19) to give (6-chloro-pyridin-2-yl)-carbamic acid tert-butyl ester as a white solid. (Yield 31.0 g, 87.4percent).
63.4%
Stage #1: With sodium hexamethyldisilazane In tetrahydrofuran at 0℃;
Stage #2: at 0 - 20℃; for 1 h;
NaHMDS (351 ml, 0.7mol) in THF (300 ml) was cooled to 0 °C, a solution of 2-amino-6- chloropyridine (107; 40 g, 0.3 1 1 mol) in THF (300 ml) was added, followed by a solution of di- tert-butyl dicarbonate(68 g, 0.3 1 1 mol) in THF, ensuring the internal temperature remained below 0 °C. The resulting reaction mixture was aged for 1 h at room temp and then careful ly acidified to pH 3 by addition of 1 M hydrochloric acid, extracted with EtOAc, the combined organic layers were then washed sequentially with saturated aqueous NaHCCh and brine, dried over Na2S04, filtered, concentrated to afford crude product, Triturated with ether to afforded desired product tert-butyl 6-chloropyridin-2-ylcarbamate (108; 45g, yield 63.4percent). M S (ESI) calcd for C,oH,3CIN202 (m/z) 228.69.

Reference: [1] Patent: US2011/21500, 2011, A1, . Location in patent: Page/Page column 45
[2] Patent: US2011/172218, 2011, A1, . Location in patent: Page/Page column 29
[3] Patent: US2012/149698, 2012, A1, . Location in patent: Page/Page column 26
[4] Journal of Organic Chemistry, 2005, vol. 70, # 5, p. 1771 - 1779
[5] Patent: US2009/258877, 2009, A1, . Location in patent: Page/Page column 16-17
[6] Patent: US2010/113441, 2010, A1, . Location in patent: Page/Page column 48
[7] Patent: US2011/144131, 2011, A1, . Location in patent: Page/Page column 19
[8] Patent: US2011/190316, 2011, A1, . Location in patent: Page/Page column 11
[9] Patent: US2012/184562, 2012, A1, . Location in patent: Page/Page column 8; 34; 35
[10] Journal of Medicinal Chemistry, 2000, vol. 43, # 16, p. 3134 - 3147
[11] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 22, p. 6368 - 6372
[12] Patent: WO2011/59839, 2011, A1, . Location in patent: Page/Page column 112-113
[13] Patent: US5410057, 1995, A,
[14] Patent: WO2007/16087, 2007, A2, . Location in patent: Page/Page column 49; 65
[15] Patent: WO2006/41830, 2006, A2, . Location in patent: Page/Page column 54-55
[16] Patent: WO2006/44504, 2006, A1, . Location in patent: Page/Page column 79
[17] Patent: WO2006/99268, 2006, A2, . Location in patent: Page/Page column 65
[18] Patent: CN104987333, 2017, B, . Location in patent: Paragraph 0029; 0030; 0042; 0049; 0056
[19] Patent: US2018/50992, 2018, A1, . Location in patent: Paragraph 1391
  • 5
  • [ 5350-93-6 ]
  • [ 24424-99-5 ]
  • [ 159603-71-1 ]
YieldReaction ConditionsOperation in experiment
88%
Stage #1: at 0℃; Inert atmosphere
Stage #2: With sodium hexamethyldisilazane In tetrahydrofuran at 20℃;
Stage #3: With hydrogenchloride In tetrahydrofuran; water
Example 24A
tert-Butyl (6-chloropyridin-2-yl)carbamate
Under argon, 150 ml of THF were added to 23.4 g (181.8 mmol) of 2-chloro-5-aminopyridine and the mixture was cooled to 0° C. 73.3 g (400 mmol) of bis(trimethylsilyl)sodium amide and 43.65 g (200 mmol) of di-tert-butyl dicarbonate, dissolved in 150 ml of THF, were added dropwise.
After 15 min, the cooling bath was removed and the mixture was stirred for a further 15 min at RT. The THF was removed using a rotary evaporator, ethyl acetate and 0.5 N hydrochloric acid were added and the mixture was extracted.
The organic phase was separated off, dried over magnesium sulfate and concentrated on a rotary evaporator.
The reaction mixture was chromatographed on silica gel (mobile phase dichloromethane/methanol 100percent100:3).
This gave 36.54 g (88percent of theory) of the product as a solid.
LCMS (method 3): Rt=2.41 min. (m/z=175 (M+H)+).
1H-NMR (400 MHz, DMSO-d6): δ=10.11 (s, 1H), 7.78 (d, 2H), 7.1 (t, 1H), 1.47 (s, 9H).
Reference: [1] Patent: US2011/53929, 2011, A1, . Location in patent: Page/Page column 19
  • 6
  • [ 45644-21-1 ]
  • [ 75-44-5 ]
  • [ 75-65-0 ]
  • [ 159603-71-1 ]
Reference: [1] Patent: US2013/5981, 2013, A1, . Location in patent: Page/Page column 9
  • 7
  • [ 4684-94-0 ]
  • [ 75-65-0 ]
  • [ 159603-71-1 ]
Reference: [1] Australian Journal of Chemistry, 1982, vol. 35, # 10, p. 2025 - 2034
  • 8
  • [ 19099-93-5 ]
  • [ 159603-71-1 ]
  • [ 883984-95-0 ]
YieldReaction ConditionsOperation in experiment
54%
Stage #1: With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran at -78℃; for 2.83333 h; Inert atmosphere
Stage #2: at -78 - 40℃; Inert atmosphere
Stage #3: With water; sodium hydrogencarbonate In tetrahydrofuran
Step 2:
benzyl 7'-chloro-2'-oxo-1',2'-dihydrospiro[piperidine-4,4'-pyrido[2,3d][1,3]-oxazin]-1-carboxylate
Under a nitrogen atmosphere 26 mL (1734 mmol) N,N,N,N-tetramethylenethylenediamine in 180 mL THF were cooled to -20° C. and 70 mL (175 mmol) of a 2.5 molar butyllithium solution were added within 10 min.
After 30 minutes' stirring the reaction mixture was cooled to -78° C. and at this temperature 17.8 g (78.0 mmol) tert-butyl (6-chloro-pyridin-2-yl)-carbamate in 120 mL THF were added dropwise within 20 min.
The reaction mixture was stirred for 2.5 h at -78° C. and then 27.2 g (116.7 mmol) benzyl 4-oxo-piperidine-1-carboxylate in 60 mL THF were added within 10 min.
After another hour's stirring at -78° C. the reaction mixture was first of all heated to RT and then stirred for 18 h at 40° C.
Then the reaction mixture was decomposed by the dropwise addition of 150 mL saturated sodium hydrogen carbonate solution.
Then the reaction mixture was extracted several times with DCM.
The combined organic phases were washed with water, dried and evaporated down.
The residue was triturated with PE/EtOAc 1/1, the precipitate formed was suction filtered, washed with PE/ETOAc 1/1 and dried.
Yield: 16.4 g (54percent of theoretical)
ESI-MS: m/z=388 (M+H)+
Rt(HPLC): 1.57 min (method C)
54%
Stage #1: With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran at -78℃; for 2.5 h; Inert atmosphere
Stage #2: at -78 - 40℃; for 19 h;
Step 2: benzyl-7'-chloro-2'-oxo-1',2'-dihydrospiro[piperidin-4,4'-pyrido[2,3d][1,3]oxazin]-1-carboxylate; Under a nitrogen atmosphere 26.0 mL (173 mmol) N,N,N,N-tetramethylene-ethylenediamine in 180 mL THF were cooled to -20° C. and combined with 70.0 mL (175 mmol) 2.5 M butyllithium solution. After 30 minutes' stirring the reaction mixture was cooled to -78° C., and at this temperature 17.8 g (78.0 mmol) tert-butyl (6-chloro-pyridin-2-yl)-carbamate in 120 mL THF were slowly added dropwise. The reaction mixture was stirred for 2.5 h at -78° C. and then combined with 27.2 g (117 mmol) Cbz-protected piperidone in 60 mL of THF. After one hour at -78° C. the mixture was heated to RT and then stirred for 18 h at 40° C. The reaction mixture was decomposed by the dropwise addition of 150 mL saturated sodium hydrogen carbonate solution. Then it was extracted with DCM. The combined organic phases were washed with water, dried and evaporated down. The residue was triturated with PE/EtOAc (1/1), the precipitate formed was suction filtered, washed with PE/EtOAc (1/1) and dried.Yield: 16.4 g (54percent of theoretical)ESI-MS: m/z=388 (M+H)+ Rt(HPLC): 1.57 min (method B)
54% With n-butyllithium; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran at -78 - 40℃; Inert atmosphere Step 2: benzyl 7'-chloro-2'-oxo-1',2'-dihydrospiro[piperidine-4,4'-pyrido[2,3d]-[1,3]oxazine]-1-carboxylate Under a nitrogen atmosphere 26 mL (173.39 mmol) N,N,N,N-tetramethylenethylene-diamine in 180 mL THF were cooled to -20° C. and within 10 min 70 mL (175 mmol) of a 2.5 molar butyllithium solution were added. After 30 minutes' stirring the reaction mixture was cooled to -78° C. and at this temperature 17.84 g (78.00 mmol) tert-butyl (6-chloro-pyridin-2-yl)-carbamate in 120 mL THF were added dropwise within 20 min. The reaction mixture was stirred for 2.5 h at -78° C. and then combined with 27.22 g (116.70 mmol) Z-piperidone in 60 mL THF within 10 min. After a further hour's stirring at -78° C. the reaction mixture was first of all heated to RT and then stirred for 18 h at 40° C. Then the reaction mixture was decomposed by the dropwise addition of 150 mL saturated sodium hydrogen carbonate solution. Then the reaction mixture was extracted several times extracted with DCM. The combined organic phases were washed with water, dried and evaporated down. The residue was triturated with PE/EtOAc 1/1, the precipitate formed was suction filtered, washed with PE/ETOAc 1/1 and dried.Yield: 16.40 g (54percent of theoretical)ESI-MS: m/z=388 (M+H)+ Rt(HPLC): 1.57 min (method C)
Reference: [1] Patent: US2011/21500, 2011, A1, . Location in patent: Page/Page column 45-46
[2] Patent: US2011/172218, 2011, A1, . Location in patent: Page/Page column 29-30
[3] Patent: US2012/149698, 2012, A1, . Location in patent: Page/Page column 26
[4] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 22, p. 6368 - 6372
[5] Patent: WO2006/41830, 2006, A2, . Location in patent: Page/Page column 55
[6] Patent: WO2006/44504, 2006, A1, . Location in patent: Page/Page column 79
[7] Patent: WO2006/99268, 2006, A2, . Location in patent: Page/Page column 65-66
[8] Patent: US2018/50992, 2018, A1, . Location in patent: Paragraph 1392
  • 9
  • [ 159603-71-1 ]
  • [ 52471-07-5 ]
Reference: [1] Patent: US2011/190316, 2011, A1,
  • 10
  • [ 159603-71-1 ]
  • [ 1206161-97-8 ]
Reference: [1] Patent: CN104987333, 2017, B,
  • 11
  • [ 159603-71-1 ]
  • [ 1303588-27-3 ]
Reference: [1] Patent: WO2011/59839, 2011, A1,
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 159603-71-1 ]

Filgotinib Related Intermediates

Chemical Structure| 39093-93-1

[ 39093-93-1 ]

Thiomorpholine 1,1-dioxide

Chemical Structure| 1010120-55-4

[ 1010120-55-4 ]

5-Bromo[1,2,4]triazolo[1,5-a]pyridin-2-amine

Chemical Structure| 45644-21-1

[ 45644-21-1 ]

2-Amino-6-chloropyridine

Chemical Structure| 19798-81-3

[ 19798-81-3 ]

6-Bromopyridin-2-amine

Chemical Structure| 59016-93-2

[ 59016-93-2 ]

4-(Hydroxymethyl)benzeneboronic acid

Related Functional Groups of
[ 159603-71-1 ]

Chlorides

Chemical Structure| 1017789-38-6

[ 1017789-38-6 ]

tert-Butyl (4,6-dichloropyridin-2-yl)carbamate

Similarity: 0.90

Chemical Structure| 1622407-12-8

[ 1622407-12-8 ]

tert-Butyl (6-chloro-3-iodopyridin-2-yl)carbamate

Similarity: 0.85

Chemical Structure| 1640995-60-3

[ 1640995-60-3 ]

tert-Butyl ((6-chloropyridin-2-yl)methyl)carbamate

Similarity: 0.77

Chemical Structure| 1244949-72-1

[ 1244949-72-1 ]

tert-Butyl (2,6-dichloropyrimidin-4-yl)carbamate

Similarity: 0.76

Chemical Structure| 171178-45-3

[ 171178-45-3 ]

tert-Butyl (6-chloropyridin-3-yl)carbamate

Similarity: 0.76

Amides

Chemical Structure| 1017789-38-6

[ 1017789-38-6 ]

tert-Butyl (4,6-dichloropyridin-2-yl)carbamate

Similarity: 0.90

Chemical Structure| 38427-94-0

[ 38427-94-0 ]

tert-Butyl pyridin-2-ylcarbamate

Similarity: 0.88

Chemical Structure| 1622407-12-8

[ 1622407-12-8 ]

tert-Butyl (6-chloro-3-iodopyridin-2-yl)carbamate

Similarity: 0.85

Chemical Structure| 220731-04-4

[ 220731-04-4 ]

tert-Butyl (5-aminopyridin-2-yl)carbamate

Similarity: 0.84

Chemical Structure| 639091-78-4

[ 639091-78-4 ]

tert-Butyl (4-(aminomethyl)pyridin-2-yl)carbamate

Similarity: 0.84

Amines

Chemical Structure| 1017789-38-6

[ 1017789-38-6 ]

tert-Butyl (4,6-dichloropyridin-2-yl)carbamate

Similarity: 0.90

Chemical Structure| 38427-94-0

[ 38427-94-0 ]

tert-Butyl pyridin-2-ylcarbamate

Similarity: 0.88

Chemical Structure| 1622407-12-8

[ 1622407-12-8 ]

tert-Butyl (6-chloro-3-iodopyridin-2-yl)carbamate

Similarity: 0.85

Chemical Structure| 220731-04-4

[ 220731-04-4 ]

tert-Butyl (5-aminopyridin-2-yl)carbamate

Similarity: 0.84

Chemical Structure| 639091-78-4

[ 639091-78-4 ]

tert-Butyl (4-(aminomethyl)pyridin-2-yl)carbamate

Similarity: 0.84

Related Parent Nucleus of
[ 159603-71-1 ]

Pyridines

Chemical Structure| 1017789-38-6

[ 1017789-38-6 ]

tert-Butyl (4,6-dichloropyridin-2-yl)carbamate

Similarity: 0.90

Chemical Structure| 38427-94-0

[ 38427-94-0 ]

tert-Butyl pyridin-2-ylcarbamate

Similarity: 0.88

Chemical Structure| 1622407-12-8

[ 1622407-12-8 ]

tert-Butyl (6-chloro-3-iodopyridin-2-yl)carbamate

Similarity: 0.85

Chemical Structure| 220731-04-4

[ 220731-04-4 ]

tert-Butyl (5-aminopyridin-2-yl)carbamate

Similarity: 0.84

Chemical Structure| 639091-78-4

[ 639091-78-4 ]

tert-Butyl (4-(aminomethyl)pyridin-2-yl)carbamate

Similarity: 0.84